Results 211 to 220 of about 146,764 (292)

Resultados de la resección sacra en cáncer rectal recurrente [PDF]

, 2006
Heriberto Medina‐Franco, Miriam N. García-Álvarez   +1 more
openalex  

Comprehensive Genomic Profiling of Advanced Anal Adenocarcinoma in Japan. [PDF]

JCO Precis Oncol
Ogura N, Hirano H, Shiraishi K, Fujii H, Hirose T, Shoji H, Okita N, Takashima A, Koyama T, Yonemori K, Kato K.   +10 more
europepmc   +1 more source

Obstrucción intestinal por metástasis en íleon terminal de carcinoma mamario lobulillar [PDF]

, 2007
Bermejo Navas, Alfonso, Bernardos García, Carlos, Galindo Galindo, Antonio Jesús, Jiménez Rodríguez, Rosa M., Palacios González, María del Carmen, Prendes Sillero, Emilio José, Sousa Vaquero, José María   +6 more
core   +1 more source

Decoding the Pathophysiology of Autoimmune Diseases—Mechanism, Triggers, and Nanotherapeutics: A Review

Advanced NanoBiomed Research, EarlyView.
This review highlights how autoimmune diseases arise from intertwined immunological, genetic, and environmental factors, emphasizing gut microbiota dysbiosis as a pivotal driver. It outlines emerging nanotechnology‐based strategies—such as liposomes, hydrogels, and polymeric nanoparticles—that enhance targeted drug delivery, minimize systemic toxicity,
Md. Meraj Ansari, Yunhui Min, Eun‐Ju Ko, Doyoung Kwon, Rehan Khan, Young‐Ok Son   +5 more
wiley   +1 more source

Bacterial Pigments as Potential Antitumor Agents Against Gastrointestinal Cancers: A Comprehensive Systematic Review

Biotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Gastrointestinal cancers (GICs) constitute one of the leading causes of cancer‐related morbidity and mortality worldwide. Despite currently available therapeutic strategies, new approaches and procedures are needed for their prevention and treatment.
Raúl Vergara, Ricardo F. S. Pereira, Carla C. C. R. de Carvalho, Jose Prados, Consolación Melguizo, Raul Ortiz   +5 more
wiley   +1 more source

Association of dietary carbohydrate intake, glycemic index, and glycemic load with colorectal cancer risk in adults: a systematic review and dose-response meta-analysis of prospective cohort studies. [PDF]

BMC Cancer
Mahjourian MM, Zeinalabedini M, Hanjani NA, Azadbakht L.   +3 more
europepmc   +1 more source

Impact of extended insurance coverage on survival outcomes among patients with metastatic colorectal cancer in Taiwan

British Journal of Clinical Pharmacology, EarlyView.
Aims Predetermined treatment duration limits (PTDLs) are often used by Taiwan's National Health Insurance Administration to contain healthcare costs, but they may compromise patient outcomes. Therefore, we studied Taiwan's 2017 extension of the bevacizumab PTDL from 24 to 36 weeks in metastatic colorectal cancer (mCRC) to evaluate whether prolonged ...
Wei‐Ming Huang, Chen‐Han Chueh, Chien‐Yu Tseng, Christopher N. Kaufmann, Earl J. Morris, Chiao‐En Wu, Yi‐Wen Tsai   +6 more
wiley   +1 more source

Correction: SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2025). [PDF]

Clin Transl Oncol
Aguilera MJS, Gaspá FL, González-Flores E, Mirón MLL, Mozo JLM, Del Carmen Riesco Martínez M, Vidal-Tocino R, Orduña VA, Martínez EA, García RV.   +9 more
europepmc   +1 more source

Can we Save the rectum by watchful waiting or transanal microsurgery following shorT-course radiotherapy and Additional local oR systemic Treatment for early-stage REctal Cancer? STARTREC-3 protocol for a non-randomised, multicentre, phase II platform study. [PDF]

BMJ Open
de Vries SEN, Couwenberg AM, Marijnen CAM, Beets GL, Burger JW, Chalabi M, de Groot JW, Intven M, Peulen HM, Roodhart JML, de Wilt JHW, Grotenhuis BA.   +11 more
europepmc   +1 more source

Tratamiento del dolor oncológico [PDF]

, 2006
Benítez del Rosario, Miguel Ángel
core   +1 more source